Angiotensin Converting Enzyme 2: A Double-Edged Sword

Circulation. 2020 Aug 4;142(5):426-428. doi: 10.1161/CIRCULATIONAHA.120.047049. Epub 2020 Mar 26.

Authors

Kaiming Wang¹, Mahmoud Gheblawi¹, Gavin Y Oudit¹

Affiliation

¹ Division of Cardiology, Department of Medicine, and Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Canada.

PMID: 32213097
DOI: 10.1161/CIRCULATIONAHA.120.047049

No abstract available

Keywords: COVID-19; angiotensin converting enzyme 2.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Angiotensin Receptor Antagonists / pharmacology*
Angiotensin-Converting Enzyme 2 / drug effects
Angiotensin-Converting Enzyme 2 / metabolism*
Animals
COVID-19 / virology*
COVID-19 Drug Treatment
Coronavirus Infections / drug therapy
Coronavirus Infections / virology*
Humans

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme 2